US$ 21.62
glp 1 drugs benefits The of GLP-1 beyond obesity GLP-1 agonists are often called
Description
In recent years, there has been an increase in the morbidity, disability rate,and mortality due to obesity, making ...
Learn why people explore it and what to consider before trying it.

Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials.

no major safety concerns were observed
